Upcoming Reports

Pharmaceuticals

This report provides:

• An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug designation and future growth trends; this report focuses on Non-Biologics
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Detailed discussion of successful orphan products
• Detailed analysis of blockbuster orphan drugs
• The rising influence of pharmacogenomics in the orphan drug market
• A discussion of specific rare diseases for which orphan drugs exist
• Analyses of the most promising therapeutic areas in the industry and leading orphan drugs in these areas
• An outline of legislation and regulation, including public and private agencies involved in support and development
• Technology trends analysis within the orphan drug market
• Comprehensive company profiles of major players in the industry.

Target Date: May 2013 Report ID: PHM151A Report Author: Shalini Shahani Dewan Price: $4,400

This report provides:

• An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug designation and future growth trends
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Detailed discussion of successful orphan products
• Detailed analysis of blockbuster orphan drugs
• The rising influence of pharmacogenomics in the orphan drug market
• A discussion of specific rare diseases for which orphan drugs exist
• Analysis of the most promising therapeutic areas in the industry and leading orphan drugs in these areas
• An outline of legislation and regulation, including public and private agencies involved in support and development
• Technology trends analysis within the orphan drug market
• Comprehensive company profiles of major players in the industry.

Target Date: May 2013 Report ID: PHM038D Report Author: Shalini Shahani Dewan Price: $5,450

This report provides:

• An overview of the market for regenerative medicines in bone and joint applications, whose key objectives are the utilization of living cells to repair or replace body tissue damaged by injury, disease, or the aging process
• Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Coverage of other regenerative applications, such as dental, neurologic, organ regeneration, cardiovascular, urologic, diabetes, and wound care, as well as stem cell research
• Identification of market drivers, including an increase in diseases and disorders that will benefit from these products, primarily arthritis, osteoporosis, and various types of bone and joint trauma (e.g., hip fractures, knee injuries); increasing use of nonautograft products by physicians; and innovative devices that incorporate bone- and cartilage-growth-stimulating agents in a regenerative appliance
• Descriptions of products, such as bone and cartilage grafting and regenerative products derived from autologous, allogeneic, and synthetic sources, as well as electrical stimulators for bone growth and regenerative cartilage products
• Discussion of FDA clinical trials and newly approved products as well as regulatory issues affecting regenerative medicine products
• Comprehensive profiles of leading and emerging companies in the bone and joint regenerative medicine markets, along with analyses of the current and future positioning of their products and businesses in this active and rapidly changing market

Target Date: May 2013 Report ID: PHM032C Report Author: Kevin Gainer Price: $5,450

This report provides:

• An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug designation and future growth trends; this report focuses on Biologics
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Detailed discussion of successful orphan products
• Detailed analysis of blockbuster orphan drugs
• The rising influence of pharmacogenomics in the orphan drug market
• A discussion of specific rare diseases for which orphan drugs exist
• Analyses of the most promising therapeutic areas in the industry and leading orphan drugs in these areas
• An outline of legislation and regulation, including public and private agencies involved in support and development
• Technology trends analysis within the orphan drug market
• Comprehensive company profiles of major players in the industry.

Target Date: May 2013 Report ID: PHM150A Report Author: Shalini Shahani Dewan Price: $4,400

This report provides:

• An overview of the global market for human and animal (veterinary) vaccines and related vaccine technologies
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Examination of current and future strategies within the human and animal (veterinary) vaccines markets, including attenuated (live) vaccines, inactivated (killed) vaccines, conjugate vaccines, recombinant/recombinant DNA (rDNA) vaccines, subunit vaccines, toxoid vaccines, and combination vaccines
• A breakdown of the seven major categories of vaccines broken down by market shares belonging to leading manufacturers and/or suppliers
• Discussion of human and animal (veterinary) vaccines as to their prophylactic or therapeutic use, with emphasis in the meningococcal/pneumococcal vaccines, influenza vaccines, pediatric vaccines, adult/adolescent vaccines, and travel vaccines
• Analysis of significant patents and their allotments in each vaccine technology category
• Coverage of acquisitions, mergers, and alliances by companies and global organizations
• Comprehensive company profiles of major players.

Target Date: June 2013 Report ID: PHM014E Report Author: Shalini Shahani Dewan Price: $5,450

This report provides:

• An overview of the global in vitro toxicity testing market, with assessments of its growth potential over the next five years and the current market scenario for alternative measures to animal testing
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Discussion of the two major technology-based approaches, mechanistic and nonmechanistic
• Examination of technological issues, including the latest trends
• A breakdown of influential factors, such as validation of the alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives
• Identification of regulations and the different federal and international agencies that play active roles in in vitro toxicology research
• Comprehensive company profiles of major players.

Target Date: July 2013 Report ID: PHM017E Report Author: Robert Hunter Price: $5,450

This report provides:

• An overview of the global market for cancer immunology, as several companies work to be among the leaders in developing and marketing cancer immunotherapies
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Discussion of important manufacturers, technologies, and factors influencing demand
• Exploration of oncolytic virology, which attempts to develop viruses designed to attack cancer cells without damaging normal cells
• Examination of circumstances most likely to lead to advanced cancers, such as genetics, and exposure to radiation, chemical carcinogens, or biological carcinogens
• Evaluations of human immunotherapy agents, such as biological response modifiers, colony stimulating factors, interferon alpha and gamma products, interleukin products, therapeutic monoclonal antibodies, and cancer vaccines
• Reviews of government regulations, industry structure, clinical guidelines, and the current state of technology, including a patent evaluation
• Comprehensive company profiles of major players.

Target Date: July 2013 Report ID: PHM129A Report Author: Valerie Kellogg Price: $5,450

This report provides:

• An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the current and future outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Discussion of the different types of contracting companies, their roles, and the shares of the market they claim
• Examination of the effects on market growth of state-of-the-art packaging facilities as well as expensive research facilities and the capabilities of research organizations
• Coverage of the market's need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments
• Comprehensive company profiles of major players.

Target Date: July 2013 Report ID: PHM043E Report Author: Shalini Shahani Dewan Price: $5,450

This report provides:

• An overview of the global market for medicines used to quit smoking, which help in coping with nicotine withdrawal symptoms developed after a long-term addiction to tobacco
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Discussion of the history and current state of smoking cessation methods, worldwide trends in smoking, and mechanisms of actions, such as nicotine replacement therapy, nicotine receptor partial agonist, and antidepressants
• A list of pipeline products and an in-depth focus on promising pipeline candidates, as well current patents and new applications
• Examination of the factors that affect market growth, including concern over side-effects of drugs, alternative products such as e-cigarettes and snuff, and the lack of reimbursement policies for smoking cessation therapies in certain regions
• Comprehensive company profiles of major players in the industry.

Target Date: August 2013 Report ID: PHM154A Report Author: Anand Gijare Price: $5,450

This report provides:

• An overview of the state of research tools, diagnostics, and drug discovery in the global ubiquitin proteasome (UPS) research field
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Discussion of existing products on the market, and detailed analysis of the competitive environments, including new potential markets for current research projects
• Identification of two major research trends in UPS: proteasome inhibitors versus ubiquitination reaction components as drug targets; this study describes current products in each area, identifies current market participants and notes the trends that are going to affect further drug development in this area
• Comprehensive company profiles of major players.

Target Date: August 2013 Report ID: PHM066B Report Author: Marianna Tcherpakov Price: $5,450

This report provides:

• An overview of the global market for excipients in pharmaceuticals, including examinations of the effects of a crisis in the global supply chain, the demands of Quality by Design (QbD), and concerns about drug safety
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Discussion of positive trends in the industry, including the development of creative ideas in response to the need for new excipients and new levels of cooperation between major players
• Coverage of the most important issues surrounding excipients: technological, regulatory, economic, and political
• Evaluations of excipient technology by chemical compounds, functional uses, delivery systems, and finished products
• Comprehensive company profiles of suppliers and others relevant to the industry.

Target Date: August 2013 Report ID: PHM010H Report Author: Paul Evers Price: $5,450

This report provides:

• An overview of the global market for drug delivery systems, including the market as seen by the end users of the different applications
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Discussion of the current state, setbacks, innovations, and the future needs of the market
• Examination of the different categories of drug delivery, broken down by market shares of the leading manufacturers and/or suppliers, as well as acquisitions, mergers, and alliances by companies and global organizations
• Analyses of the regulatory environment, and the technology involved,  including the latest trends and developments
• Comprehensive company profiles of major players.

Target Date: September 2013 Report ID: PHM006J Report Author: Shalini Shahani Dewan Price: $5,450

This report provides:

• An overview of the global market for erythropoietin stimulating agents, including breakdowns of the market by geography, by molecule, and by branded vs. generic
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• A focus on the mechanism of action of erythropoietin, including first-generation, second-generation, and third-generation analogs
• Examination of the types of applications, such as cancer therapy, CKD therapy, and HIV therapy
• Discussion of the market structure, with identifications of the roles of regulatory agencies and the FDA, the industry structure, and major companies and market shares
• Evaluations of market dynamics, such as trends in price and price/performance, as well as technology, patents, product development, and clinical trials
• Comprehensive company profiles of major suppliers.

Target Date: September 2013 Report ID: PHM130A Report Author: Gunjan Bhatia Price: $5,450

This report provides:

• An overview of the global market for peptide hormones
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2017
• A breakdown by hormones of the hypothalamus, the anterior pituitary, and the posterior pituitary
• Discussion of the significance of peptide hormones
• Examination of industry structure as well as major companies' market shares, and pricing trends
• Evaluations of the technology and research and development based on human, preclinical, and in vitro studies
• Patent analysis
• Comprehensive company profiles of major players.

Target Date: October 2013 Report ID: PHM152A Report Author: Sujatha Vijayan Price: $5,450

This report provides:

• An overview of the global market for cancer diagnostics based on circulating tumor cells (CTC), which are used to increase understanding of tumor cell biology and metastatic cancer as a disease
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Discussion of the advantages and disadvantages of CTC enrichment techniques
• Estimations of cancer incidence, cancer deaths, new cases by type in the United States, and breast cancer statistics and facts
• Examination of growth opportunities and drivers in the CTC market and recent breakthroughs in research, along with a patent analysis
• Comprehensive company profiles of major players.

Target Date: October 2013 Report ID: PHM153A Report Author: Usha Nagavarapu Price: $5,450

This report provides:

• An overview of the global market for influenza vaccines, therapeutics, and diagnostics
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers, with a special emphasis on U.S. and European markets
• Discussion of efforts by government agencies and disease prevention organizations to support and fund research and development programs, and pandemic prevention
• Comprehensive company profiles of major players.

Target Date: October 2013 Report ID: PHM049C Report Author: Melissa Elder Price: $5,450